The state of Minnesota has added a couple of new conditions to its medical cannabis program.
The new qualifying conditions, which will take effect next year, are chronic pain and age-related macular degeneration.
The Minnesota Department of Health (MDH) will add the new conditions starting in August 2020.
“The generally positive experience patients have had using medical cannabis to treat intractable pain prompted us to add chronic pain as a qualifying condition,” Health Commissioner Jan Malcolm stated. “Meanwhile, the decision to add age-related macular degeneration was due to a lack of good treatment options for managing symptoms.”
Two new delivery methods will additionally be allowed starting next year, including “water-soluble cannabinoid multi-particulates” and orally-dissolvable products.
“We hope the addition of new delivery methods will provide a potential alternative to vaping for some patients and that the additional centers will provide more convenient access,” Commissioner Malcolm added.
